Did This 15-Year-Old Boy Just Find a Cure for Pancreatic Cancer?
Did this 15-year-old schoolboy from Crownsville, MD just find a cure for pancreatic cancer?
Not quite, but his new invention promises to bring survival rates up to nearly 100 percent.
Jack Andraka has invented a new, low-cost test to detect for the earliest stages of the deadly disease. This brilliant young mind was inspired to take action following the death of his uncle to this most dreaded disease.
A simple ‘dip test’ looks for levels of mesothelin, a biomarker for this disease, in both the blood and urine. This innovative test will potentially revolutionize treatment for pancreatic cancer—a disease which currently kills 19 of the 20 patients diagnosed within the first five years.
The test, in its earliest phase of review, is already over 90 percent accurate for detecting pancreatic cancer at it’s earliest state; where once previously this diagnosis was a near certain ‘death sentence,’ now there is hope.
And the cost of this test? Only three cents per strip.
I’ll bet that will turn the pharmaceutical heads and lobbyists right straight onto their collective ears.
Watch this video to learn a little more:
Like elephant health & wellness on Facebook.
Ed: Bryonie Wise
Incorrect source, offensive, or found a typo? Or do you want to write for Elephant?








15?! Give the kid a prize for God's sake!
A prize *and* the final patent…
Wow makes you wonder what other untapped genius might we be missing…..
Yes, it certainly does… or how much is discovered, but doesn't get noticed…
Just who we need to help in the world of science and medicine. Some one who can think out side the box!! Thanks for your hard work. Thanks for giving the world a real gift!!
Hello! I simply want to give a huge thumbs up for the good information you may have
right here on this post. I will be coming back to your blog for extra soon.
Hi there! I just want to give an enormous thumbs up for
the good information you’ve gotten here on this post.
I will be coming again to your blog for extra soon.